[company_age]10.0[/company_age][employees]2-10 employees[/employees][funding]Seed[/funding][description]PExA AB is a Swedish company that develops and markets a research instrument to study respiratory diseases. The company's unique technology enables the non-invasive collection of potential biomarkers from the small airways, which can be used to develop diagnostic products for various respiratory diseases, such as COPD, asthma, tuberculosis, cystic fibrosis, and lung cancer. PExA's business model is based on generating income from initial sales as well as from repeat sales. The company's target market includes research groups and pharmaceutical companies worldwide. PExA's board and management include individuals with extensive experience and knowledge in the field of respiratory research.[/description][ps]PExA develops and markets a research instrument to study respiratory diseases.[/ps]